Zobrazeno 1 - 10
of 190
pro vyhledávání: '"NING LOU"'
Autor:
Ruyun Gao, Ning Lou, Lin Li, Tongji Xie, Puyuan Xing, Le Tang, Jiarui Yao, Xiaohong Han, Yuankai Shi
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-15 (2024)
Abstract Introduction Identifying new biomarkers for predicting immune checkpoint inhibitors (ICIs) response in non-small cell lung cancer (NSCLC) is crucial. We aimed to assess the variant allele frequency (VAF)-related profile as a novel biomarker
Externí odkaz:
https://doaj.org/article/01d8a74ab1f0446cac8f66bf6e86e1fd
Publikováno v:
iScience, Vol 26, Iss 10, Pp 107894- (2023)
Summary: Senescent tumor cells (STCs) can induce immunosuppression, promoting tumor progression and therapy resistance. However, the specific characteristics of immunosuppressive STC have not been thoroughly investigated. This study aimed to characte
Externí odkaz:
https://doaj.org/article/a0d8da799a0a4ed4b056159a6eddc59d
Autor:
Xin Wang, Ying Wang, Xiaolan Yong, Bojun Wu, Zilin Sun, Ning Lou, Qing Wen, Yufang Zhang, Shiyun Li, Jiarui Li, Yan He, Jinluo Cheng, Xiangdong Zhong, Jing Shen, Wenying Yang
Publikováno v:
Journal of Diabetes, Vol 14, Iss 12, Pp 822-830 (2022)
Abstract Background The new xanthine dipeptidyl peptidase‐4 inhibitor yogliptin has exhibited excellent hypoglycemic activity in experimental disease models. The present work aimed to assess the efficacy of yogliptin as a monotherapy in individuals
Externí odkaz:
https://doaj.org/article/7cc74c7dbeac4893b9af0ab13fe17629
Publikováno v:
Chinese Journal of Lung Cancer, Vol 25, Iss 7, Pp 452-459 (2022)
Mucin16 (MUC16), also known as carbohydrate antigen 125 (CA125), is a glycoprotein antigen that can be recognized by the monoclonal antibody OC125 detected from epithelial ovarian carcinoma antigen by Bast et al in 1981. CA125 is not present in norma
Externí odkaz:
https://doaj.org/article/fb18bb2ae8c6437b8668f51bac62c7b4
Autor:
Shasha Wang, Ning Lou, Rongrong Luo, Xuezhi Hao, Yutao Liu, Lin Wang, Yuankai Shi, Xiaohong Han
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-16 (2022)
Abstract Background The identification of early plasma biomarkers for clinical outcomes and drug resistance has key importance for risk stratification in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) patients.
Externí odkaz:
https://doaj.org/article/f0d3819ce75f4a1c8fd070c0a85ffaee
Autor:
Yu Zhou, Shasha Wang, Yunxia Tao, Haizhu Chen, Yan Qin, Xiaohui He, Shengyu Zhou, Peng Liu, Jianliang Yang, Sheng Yang, Lin Gui, Ning Lou, Zhishang Zhang, Jiarui Yao, Xiaohong Han, Yuankai Shi
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-13 (2021)
Abstract Background This study aimed to recognize the hub genes associated with prognosis in follicular lymphoma (FL) treated with first-line rituximab combined with chemotherapy. Method RNA sequencing data of dataset GSE65135 (n = 24) were included
Externí odkaz:
https://doaj.org/article/0ab204cde19148acb3f35d1c4dd15024
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: In recent years, the number of clinical trials initiated in China has increased rapidly. The aim of this study was to overview the changing landscape of phase I clinical trials in mainland China from 2011 to 2020.Methods: We analyzed phas
Externí odkaz:
https://doaj.org/article/71566bbfae324e8db31bf740b1fb671d
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 22, Iss 6, Pp 487-494 (2018)
Background: The rate of methicillin-resistant Staphylococcus aureus (MRSA) among the total of S. aureus isolates decreased to 35.3% in 2017 in China. It is unclear whether the molecular characteristics of S. aureus isolates have changed as the rate d
Externí odkaz:
https://doaj.org/article/e4c57dc2d15a480d9deacb5e4a54c97e
Autor:
Guang-hua Xu, Ning Lou, Hang-chuan Shi, Yu-chen Xu, Hai-long Ruan, Wen Xiao, Lei Liu, Xiang Li, Hai-bing Xiao, Bin Qiu, Lin Bao, Chang-fei Yuan, Ya-li Zhou, Wen-jun Hu, Ke Chen, Hong-mei Yang, Xiao-ping Zhang
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-12 (2018)
Abstract Background Scavenger receptor class B type I (SR-BI) has been reported to be involved in carcinogenesis of several human cancers. However, it is currently unknown whether SR-BI plays a role in clear cell renal cell carcinoma (ccRCC). Here, w
Externí odkaz:
https://doaj.org/article/0ce6d580a1df449aabfe0d154ca35269
Autor:
Wen Xiao, Ning Lou, Hailong Ruan, Lin Bao, Zhiyong Xiong, Changfei Yuan, Junwei Tong, Guanghua Xu, Yali Zhou, Yan Qu, Wenjun Hu, Yaoying Gao, Zeyuan Ru, Lei Liu, Haibing Xiao, Ke Chen, Hongmei Yang, Xiaoping Zhang
Publikováno v:
Cellular Physiology and Biochemistry, Vol 43, Iss 6, Pp 2420-2433 (2017)
Background/Aims: We previously performed microRNA (miRNA) microarray to identify effective indicators of clear cell renal cell carcinoma (ccRCC) tissue samples and preoperative/postoperative plasma in which we identified miR-144-3p as an oncomiRNA. H
Externí odkaz:
https://doaj.org/article/ac48b38818bd4f62b2ced660c61eb783